{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:14:32Z","timestamp":1775852072342,"version":"3.50.1"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.2169\/internalmedicine.8579-21","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:14:41Z","timestamp":1648764881000},"page":"1085-1091","source":"Crossref","is-referenced-by-count":4,"title":["Dermatomyositis Which Was Double Positive for Anti-MDA5 and Anti-ARS Antibodies That Was Successfully Treated by Intensive Immunosuppressive Therapy"],"prefix":"10.2169","volume":"61","author":[{"given":"Satoshi","family":"Hama","sequence":"first","affiliation":[{"name":"Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misako","family":"Higashida-Konishi","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, Japan"},{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, Japan"},{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, Japan"},{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, Japan"},{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisaji","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Okano","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hamaguchi Y, Fujimoto M, Matsushita T, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-trna synthetase antibodies: heterogeneity within the syndrome. PLoS One 8: e60442, 2013.","DOI":"10.1371\/journal.pone.0060442"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mimori T, Imura Y, Nakashima R, Toshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol 19: 523-529, 2007.","DOI":"10.1097\/BOR.0b013e3282f01a8c"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nakashima R. Clinical significance of myositis-specific autoantibodies. Immunol Med 41: 103-112, 2018.","DOI":"10.1080\/25785826.2018.1531188"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hamaguchi Y, Kuwana M, Hoshino K, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multi-centre, cross-sectional study. Arch Dermatol 147: 391-398, 2011.","DOI":"10.1001\/archdermatol.2011.52"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kurtzman D, Vleugels A. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol 78: 776-785, 2018.","DOI":"10.1016\/j.jaad.2017.12.010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gono T, Kuwana M. Inflammatory myopathies: choosing the right biomarkers to predict ILD in myositis. Nat Rev Rheumatol 12: 504-506, 2016.","DOI":"10.1038\/nrrheum.2016.120"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Naniwa T, Tamechika S, Okazaki Y, Maeda S, Kuwana M. Coexistence of anti-melanoma differentiation-associated gene 5 and anti-aminoacyl-transfer RNA synthetase antibodies in a patient with dermatomyositis and rapidly progressive and relapsing interstitial lung disease. Mod Rheumatol Case Rep 1: 3-8, 2017.","DOI":"10.1080\/24725625.2016.1253650"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Takeuchi Y, Hashimoto M, Nakashima R, et al. Anti-EJ, anti-MDA5 double-positive chronic clinically amyopathic dermatomyositis: a case report. Rheumatol Adv Pract 2: rky022, 2018.","DOI":"10.1093\/rap\/rky022"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Li ZY, Gill E, Mo F, Reyes C. Double anti-PL-7 and anti-MDA-5 positive amyopathic dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient. BMC Pulm Med 20: 220, 2020.","DOI":"10.1186\/s12890-020-01256-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Koga T, Fujikawa K, Horai Y, et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford) 51: 1278-1284, 2012.","DOI":"10.1093\/rheumatology\/ker518"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Isoda K, Kotani T, Takeuchi T, et al. Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody. Rheumatol Int 37: 1335-1340, 2017.","DOI":"10.1007\/s00296-017-3729-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tanizawa K, Handa T, Nakashima R, et al. HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med 105: 1380-1387, 2011.","DOI":"10.1016\/j.rmed.2011.05.006"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Nakashima R, Hosono Y, Mimori T. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease. Lupus 25: 925-933, 2016.","DOI":"10.1177\/0961203316651748"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Waseda Y, Johkoh T, Egashira R, et al. Antisynthetase syndrome: pulmonary computed tomography findings of adult patients with antibodies to aminoacyl-tRNA synthetases. Eur J Radiol 85: 1421-1426, 2016.","DOI":"10.1016\/j.ejrad.2016.05.012"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hervier B, Wallaert B, Hachulla E, et al. Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. Rheumatology (Oxford) 49: 972-976, 2010.","DOI":"10.1093\/rheumatology\/kep455"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rohit A, Elaine C, Noreen F, et al. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 73: 227-232, 2014.","DOI":"10.1136\/annrheumdis-2012-201800"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sato S, Kuwana M, Fujita T, Suzuki Y. Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol 23: 496-502, 2013.","DOI":"10.3109\/s10165-012-0663-4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Matsushita T, Mizumaki K, Kano M, et al. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol 176: 395-402, 2017.","DOI":"10.1111\/bjd.14882"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kerry B, Oddis CV, Fertig N, et al. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum 56: 3125-3131, 2007.","DOI":"10.1002\/art.22865"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Paige W, David F. Dermatomyositis clinical and pathological phenotypes associated with myositis-specific autoantibodies. Curr Rheumatol Rep 20: 28, 2018.","DOI":"10.1007\/s11926-018-0733-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. David F, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 65: 25-34, 2011.","DOI":"10.1016\/j.jaad.2010.09.016"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sugimori Y, Yamashita H, Yorifuji H, et al. A case of clinically amyopathic dermatomyositis with hoarseness due to vocal cord necrosis. J Clin Rheumatol 24: 50-51, 2018.","DOI":"10.1097\/RHU.0000000000000575"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kang EH, Go DJ, Mimori T, et al. Novel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patients. Semin Arthritis Rheum 49: 283-287, 2019.","DOI":"10.1016\/j.semarthrit.2019.03.005"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lin JM, Zhang YB, Peng QL, et al. Genetic association of HLA-DRB1 multiple polymorphisms with dermatomyositis in Chinese population. HLA 90: 354-359, 2017.","DOI":"10.1111\/tan.13171"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Chen Z, Wang Y, Kuwana M, et al. HLA-DRB1 alleles as genetic risk factors for the development of anti-MDA5 antibodies in patients with dermatomyositis. J Rheumatol 44: 1389-1393, 2017.","DOI":"10.3899\/jrheum.170165"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Gono T, Kawaguchi Y, Kuwana M, et al. Brief report: association of HLA-DRB1*0101\/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population. Arthritis Rheum 64: 3736-3740, 2012.","DOI":"10.1002\/art.34657"},{"key":"27","unstructured":"27. Furuya T, Hakoda M, Tsuchiya N, et al. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy. J Rheumatol 31: 1768-1774, 2004."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/7\/61_8579-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:11:25Z","timestamp":1715231485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/7\/61_8579-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8579-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"article-number":"8579-21"}}